` CLVSF (CellaVision AB) vs S&P 500 Comparison - Alpha Spread

CLVSF
vs
S&P 500

Over the past 12 months, CLVSF has underperformed S&P 500, delivering a return of -34% compared to the S&P 500's +15% growth.

Stocks Performance
CLVSF vs S&P 500

Loading
CLVSF
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CLVSF vs S&P 500

Loading
CLVSF
S&P 500
Difference
www.alphaspread.com

Performance By Year
CLVSF vs S&P 500

Loading
CLVSF
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
CellaVision AB vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

CellaVision AB
Glance View

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CLVSF Intrinsic Value
25.93 USD
Undervaluation 34%
Intrinsic Value
Price
Back to Top